We are live on
!
Find out more
RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
26 hedge funds and large institutions have $6.8M invested in Regulus Therapeutics in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.43% less ownership
Funds ownership: 48.2% → 47.77% (-0.43%)
4% less funds holding
Funds holding: 27 → 26 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
39% less capital invested
Capital invested by funds: $11.1M → $6.8M (-$4.27M)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Holders
26
Holders Change
-1
Holders Change %
-3.7%
% of All Funds
0.41%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
4
Increased
3
Reduced
5
Closed
5
Calls
$329K
Puts
–
Net Calls
+$329K
Net Calls Change
-$625K
Top Buyers
| 1 |
Jane Street
New York
|
+$24.1K |
| 2 |
LPL Financial
San Diego,
California
|
+$17.9K |
| 3 |
GC
Grimes & Company
Westborough,
Massachusetts
|
+$13.7K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.38K |
| 5 |
Renaissance Technologies
New York
|
+$5.29K |
Top Sellers
| 1 |
BlackRock
New York
|
-$58.3K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$48.6K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$9.02K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$5.19K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$398 |
